The Genomate Health team — Istvan Petak, MD, PhD, Founder and Chief Scientific Officer, Barbara Vodicska, PhD, Head of Translational Science, and Robert Doczi, PhD, DSc, Head of Research — will attend the ESMO Congress 2025 in Berlin.

We are looking forward to joining the global oncology community to explore how innovation, collaboration, and computational reasoning are shaping the future of precision oncology.

At Genomate Health, we believe that precision oncology must be consistent, accessible, and actionable wherever care is delivered. We are attending ESMO 2025 to listen, learn, and connect with others who share the same goal.

If you are thinking about the challenges of decision support, biomarker-driven therapy, or scaling precision beyond academic centers, let’s find time to talk.

October 17–21, 2025 | Berlin, Germany
Contact us: info(at)genomate.health